Sanofi/Regeneron unveil more positive data for PCSK9 inhibitor

12th June 2017 Uncategorised 0

Sanofi and Regeneron have unveiled new data further backing the safety and efficacy of PCSK9 inhibitor Praluent in lowering cholesterol in patients with diabetes.

More: Sanofi/Regeneron unveil more positive data for PCSK9 inhibitor
Source: News